| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| J9271 |
Injection, pembrolizumab, 1 mg |
246 |
169 |
$2.22M |
| J1745 |
Injection, infliximab, excludes biosimilar, 10 mg |
807 |
429 |
$1.12M |
| 96413 |
Chemotherapy administration, intravenous infusion; up to 1 hour, single or initial substance |
9,524 |
5,395 |
$848K |
| J1459 |
Injection, immune globulin (privigen), intravenous, non-lyophilized (e.g., liquid), 500 mg |
464 |
266 |
$672K |
| 96365 |
Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour |
5,889 |
3,899 |
$317K |
| J1439 |
Injection, ferric carboxymaltose, 1 mg |
298 |
198 |
$225K |
| 96375 |
Therapeutic injection; each additional sequential IV push |
9,516 |
5,053 |
$193K |
| J1569 |
Injection, immune globulin, (gammagard liquid), non-lyophilized, (e.g., liquid), 500 mg |
245 |
98 |
$190K |
| 36430 |
|
1,181 |
807 |
$182K |
| 96417 |
|
2,309 |
1,295 |
$130K |
| J1453 |
Injection, fosaprepitant, 1 mg |
1,707 |
975 |
$119K |
| 96409 |
|
1,766 |
1,181 |
$117K |
| Q0138 |
Injection, ferumoxytol, for treatment of iron deficiency anemia, 1 mg (non-esrd use) |
523 |
282 |
$117K |
| J2469 |
Injection, palonosetron hcl, 25 mcg |
3,935 |
2,072 |
$110K |
| 96374 |
Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance |
3,389 |
2,119 |
$97K |
| J1756 |
Injection, iron sucrose, 1 mg |
1,628 |
905 |
$93K |
| 96367 |
|
3,229 |
1,900 |
$93K |
| 96366 |
Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour |
3,021 |
2,144 |
$92K |
| 96411 |
|
1,949 |
1,128 |
$82K |
| 96415 |
|
3,209 |
2,076 |
$79K |
| 96361 |
Intravenous infusion, hydration; each additional hour |
4,731 |
2,984 |
$74K |
| 96360 |
Intravenous infusion, hydration; initial, 31 minutes to 1 hour |
1,320 |
731 |
$56K |
| J0185 |
Injection, aprepitant, 1 mg |
369 |
206 |
$52K |
| 96416 |
|
454 |
251 |
$46K |
| Q5104 |
Injection, infliximab-abda, biosimilar, (renflexis), 10 mg |
29 |
25 |
$44K |
| J0640 |
Injection, leucovorin calcium, per 50 mg |
643 |
209 |
$12K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
2,901 |
2,013 |
$10K |
| Q5111 |
Injection, pegfilgrastim-cbqv (udenyca), biosimilar, 0.5 mg |
29 |
12 |
$9K |
| J7040 |
Infusion, normal saline solution, sterile (500 ml = 1 unit) |
11,406 |
6,307 |
$8K |
| C9463 |
Injection, aprepitant, 1 mg |
23 |
12 |
$6K |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
6,180 |
3,059 |
$5K |
| J9045 |
Injection, carboplatin, 50 mg |
213 |
120 |
$5K |
| J9190 |
Injection, fluorouracil, 500 mg |
717 |
296 |
$4K |
| J7030 |
Infusion, normal saline solution , 1000 cc |
2,470 |
1,308 |
$3K |
| 90460 |
Immunization administration through 18 years of age via any route, first or only component |
176 |
169 |
$3K |
| J9370 |
Vincristine sulfate, 1 mg |
474 |
334 |
$3K |
| J3490 |
Unclassified drugs |
204 |
129 |
$2K |
| P9016 |
Red blood cells, leukocytes reduced, each unit |
42 |
27 |
$2K |
| 96368 |
|
135 |
87 |
$2K |
| J1200 |
Injection, diphenhydramine hcl, up to 50 mg |
3,124 |
1,701 |
$2K |
| J2919 |
Injection, methylprednisolone sodium succinate, 5 mg |
96 |
40 |
$941.17 |
| J2405 |
Injection, ondansetron hydrochloride, per 1 mg |
1,419 |
761 |
$844.25 |
| J2930 |
Injection, methylprednisolone sodium succinate, up to 125 mg |
20 |
12 |
$632.89 |
| J3420 |
Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg |
319 |
223 |
$574.04 |
| J9263 |
Injection, oxaliplatin, 0.5 mg |
31 |
12 |
$482.64 |
| J1626 |
Injection, granisetron hydrochloride, 100 mcg |
120 |
60 |
$298.11 |
| J3475 |
Injection, magnesium sulfate, per 500 mg |
75 |
31 |
$109.68 |
| J7050 |
Infusion, normal saline solution, 250 cc |
99 |
79 |
$66.87 |
| J9250 |
Methotrexate sodium, 5 mg |
23 |
13 |
$45.33 |
| J3480 |
Injection, potassium chloride, per 2 meq |
62 |
24 |
$28.24 |